News Feature

In 2012, a pair of neurosurgery residents traded their scrubs for lab coats in an effort to understand, at the most basic level, what causes medulloblastoma, the most common pediatric brain cancer.

Sixty medical students presented a broad array of projects at this year’s medical student research symposium.

The former associate dean at the Stanford School of Medicine helped form a minority admissions council that increased the number of students from underrepresented groups.

The Stanford-led research tested an approach that allowed women to choose the level of pain management they wanted during a cesarean section.

Canagliflozin, a drug approved to lower glucose levels in diabetic patients, can slow the progression of kidney disease, according to a study co-authored by a Stanford Medicine researcher.

Stanford scientists and their collaborators found markers of immune-related stress and other molecular changes in the body of NASA astronaut Scott Kelly.

In preclinical trials, Stanford scientists and their collaborators harnessed the gene-editing system CRISPR-Cas9 to replace the mutated gene underpinning the devastating immune disease.

Through a combination of biometric tracking, simulated modeling and medical imaging, Stanford researchers have detailed how hits to the side of the head may cause concussion.

On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the thinking in his field about what causes a common and often lethal heart defect.

Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.